Wolff Wiese Magana’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Sell
2,520
-41
-2% -$41.9K 1.39% 19
2026
Q1
$2.36M Buy
2,561
+141
+6% +$143K 1.3% 26
2025
Q4
$2.6M Buy
2,420
+4
+0.2% +$3.83K 1.42% 21
2025
Q3
$1.84M Sell
2,416
-935
-28% -$696K 1.04% 31
2025
Q2
$2.61M Buy
3,351
+999
+42% +$776K 1.62% 17
2025
Q1
$1.94M Buy
2,352
+555
+31% +$462K 1.32% 27
2024
Q4
$1.39M Buy
1,797
+52
+3% +$43.1K 0.92% 40
2024
Q3
$1.55M Buy
1,745
+35
+2% +$31.5K 1.06% 31
2024
Q2
$1.55M Buy
1,710
+5
+0.3% +$4K 1.23% 29
2024
Q1
$1.33M Buy
1,705
+170
+11% +$121K 1.14% 34
2023
Q4
$895K Sell
1,535
-20
-1% -$11.7K 0.85% 42
2023
Q3
$835K Buy
1,555
+1,398
+890% +$720K 0.68% 50
2023
Q2
$73.6K Sell
157
-20
-11% -$8.39K 0.06% 159
2023
Q1
$60.8K Sell
177
-4
-2% -$1.35K 0.05% 170
2022
Q4
$66.2K Sell
181
-350
-66% -$124K 0.06% 159
2022
Q3
$172K Sell
531
-38
-7% -$12K 0.14% 120
2022
Q2
$185K Buy
569
+79
+16% +$23.7K 0.14% 116
2022
Q1
$141K Sell
490
-13
-3% -$3.35K 0.09% 146
2021
Q4
$139K Sell
503
-1
-0.2% -$254 0.09% 167
2021
Q3
$116K Buy
504
+13
+3% +$3.21K 0.08% 181
2021
Q2
$113K Buy
491
+68
+16% +$13.7K 0.08% 173
2021
Q1
$79K Sell
423
-146
-26% -$28.6K 0.06% 216
2020
Q4
$96K Buy
+569
New +$85K 0.08% 184

Other funds holding LLY

Wolff Wiese Magana's LLY Position: Q2 2026 in Review

Wolff Wiese Magana reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $41.9K and leaving 2,520 shares worth $3.02M. The position accounts for 1.39% of the portfolio, ranked #19.

Wolff Wiese Magana first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wolff Wiese Magana held 2,520 shares of Eli Lilly worth $3.02M as of Q2 2026.
  • Wolff Wiese Magana sold 41 Eli Lilly shares in Q2 2026, an estimated $41.9K.
  • Eli Lilly made up 1.39% of Wolff Wiese Magana's portfolio in Q2 2026, its #19 holding.
  • Wolff Wiese Magana first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.